Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Concentrix Corporation filings document the company’s results, governance, financing arrangements and capital structure as a public technology and services issuer. Form 8-K reports include quarterly and annual operating results, dividend and share repurchase information, material agreements, debt offerings, note redemptions and amendments to its accounts receivable securitization facility through Concentrix Receivables, Inc.
Proxy and annual meeting filings cover director elections, auditor ratification, executive compensation votes and amendments to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan. Other governance disclosures address board composition and investor-rights provisions associated with the company’s Webhelp acquisition history.
Concentrix Corp President and CEO Christopher A. Caldwell bought additional company stock in the open market. He purchased 1,000 shares of Common Stock at a price of $21.2497 per share. After this transaction, he directly owns 358,382 shares of Concentrix Common Stock.
BlackRock, Inc. filed Amendment No. 4 to a Schedule 13G/A reporting beneficial ownership of 6,534,519 shares of Concentrix Corp common stock, representing 10.7% of the class as of 06/30/2026.
The filing shows sole voting power for 6,469,134 shares and sole dispositive power for 6,534,519. The amendment includes Exhibit 24 (Power of Attorney) and Exhibit 99 (Item 7 subsidiary identification).
Concentrix Corporation reported modest revenue growth but lower profitability for the quarter and first half of fiscal 2026. Revenue for the quarter ended May 31, 2026 rose to $2.46 billion, up 1.9% year over year, while quarterly net income increased to $55.3 million from $42.1 million, helped by foreign exchange gains.
For the first six months, revenue grew 3.6% to $4.96 billion, but net income declined to $76.9 million from $112.4 million as margins compressed. Cost of revenue and selling, general and administrative expenses outpaced revenue, and the company booked $60.2 million of severance-related restructuring costs affecting about 20,000 employees.
Concentrix classified a non-core business as held for sale and agreed to sell it for approximately 15 million euros, recording a $6.9 million loss on held for sale and showing $202.7 million of assets held for sale and $172.3 million of related liabilities. The balance sheet shows total assets of $10.51 billion and long-term debt, net of costs, of $3.93 billion, including new 6.500% Senior Notes due 2029 used to redeem $600 million of 2026 notes.
Concentrix reported fiscal second quarter 2026 revenue of $2,462.5M, up 1.9% year over year, with constant currency growth of 0.6%. GAAP operating income fell to $95.4M and operating margin declined to 3.9% from 6.1%, reflecting higher costs and significant acquisition, integration and restructuring charges.
GAAP net income rose to $55.3M, up 31%, and diluted EPS increased to $0.86, while non-GAAP diluted EPS edged down to $2.63 from $2.70. Cash flow from operations reached a record second-quarter $257.9M, with adjusted free cash flow of $242.3M.
For full-year 2026, Concentrix expects reported revenue between $9.925B and $10.025B, implying constant currency growth of 0.25% to 1.25%, non-GAAP operating income of $1.20B–$1.23B, non-GAAP diluted EPS of $10.83–$11.18, and adjusted free cash flow of $630–$650M.
Concentrix Corp ownership disclosure: AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report beneficial ownership of 4,831,868 shares of Concentrix common stock, representing 7.94% of the class. The filing shows shared voting power of 4,756,220 and shared dispositive power of 4,831,868.
The filing is submitted by the two related entities with AQR Capital Management, LLC identified as a wholly owned subsidiary of AQR Capital Management Holdings, LLC and is signed by an authorized signatory.
FMR LLC reported beneficial ownership of 4,223,281.76 shares of Concentrix Corp common stock, representing 6.9% of the class as of 03/31/2026. The filing lists sole dispositive power for 4,223,281.76 shares and sole voting power of 4,210,007 shares. The report is submitted on Schedule 13G and references an Exhibit 99 and a power of attorney.
Concentrix Corporation reported a change in its Board of Directors tied to ownership conditions in an Investor Rights Agreement related to its September 2023 Webhelp acquisition. Groupe Bruxelles Lambert SA (GBL) previously had the right to nominate one director as long as it beneficially owned at least 50% of the Concentrix shares issued to it in that deal.
On April 29, 2026, GBL entered into a transaction that reduced its beneficial ownership below this Board Nomination Threshold. As a result, GBL’s nominee, Bilge Ogut, resigned from the Concentrix Board and its committees, effective immediately.
Groupe Bruxelles Lambert and affiliates have sharply reduced their stake in Concentrix Corporation. Through subsidiaries including Sapiens S.à r.l., FINPAR V and FINPAR VI, they now beneficially own 2,773,667 shares of Common Stock, representing 4.55% of Concentrix’s 61,004,826 outstanding shares as of March 31, 2026.
The change follows Sapiens’ April 29, 2026 block trade of 6,000,000 shares at $22.25 per share under Rule 144, which brought the group’s holdings below the 5% reporting threshold, ending their ongoing Schedule 13D reporting obligations. They may also receive up to 442,759 contingent Earnout Shares if share-price conditions set in a prior agreement are met.
Entities associated with Groupe Bruxelles Lambert reported a major sale of Concentrix Corp stock. FINPAR VI SA, FINPAR V SA and Sapiens S.a r.l. reported an open‑market sale of 6,000,000 shares of Concentrix common stock at $22.25 per share on April 29, 2026.
After this transaction, the reporting entities collectively report indirect ownership of 2,773,667 Concentrix shares, with 38,623 shares held by FINPAR VI SA, 35,964 by FINPAR V SA and 2,699,080 by Sapiens S.a r.l.
CNXC filed a Form 144 reporting a proposed sale of Common Stock. The notice is dated 04/29/2026 and cites shares of common stock received in exchange pursuant to a Share Purchase and Contribution Agreement dated June 12, 2023. The exchange recorded 8,699,080 shares on 09/25/2023.